The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Epirubicin (EPI) Docetaxel (DOCE) - Pharmacokinetics (PK) of the Combination in Breast Cancer Patients.
 
Thomas Benjamin Karasic
No Relationships to Disclose
 
Mark H. O'Hara
No Relationships to Disclose
 
Ursina R. Teitelbaum
No Relationships to Disclose
 
Nevena Damjanov
Honoraria - Daiichi Sankyo (I); Sirtex Medical
Consulting or Advisory Role - Amgen; Bayer; Celgene
 
Bruce J. Giantonio
No Relationships to Disclose
 
Tracy S. d'Entremont
No Relationships to Disclose
 
Maryann Gallagher
No Relationships to Disclose
 
Paul J. Zhang
No Relationships to Disclose
 
Peter J. O'Dwyer
Consulting or Advisory Role - Bristol-Myers Squibb; Five Prime Therapeutics; Forty Seven; Genentech
Research Funding - Amgen; Bayer; BBI Healthcare; Bristol-Myers Squibb; Celgene; Five Prime Therapeutics; Forty Seven; Genentech; GlaxoSmithKline; Merck; Mirati Therapeutics; Novartis; Pfizer; Pharmacyclics